ES2126057T3 - Derivados de ester hexahidronaftaleno, su preparacion y sus aplicaciones terapeuticas. - Google Patents

Derivados de ester hexahidronaftaleno, su preparacion y sus aplicaciones terapeuticas.

Info

Publication number
ES2126057T3
ES2126057T3 ES94300557T ES94300557T ES2126057T3 ES 2126057 T3 ES2126057 T3 ES 2126057T3 ES 94300557 T ES94300557 T ES 94300557T ES 94300557 T ES94300557 T ES 94300557T ES 2126057 T3 ES2126057 T3 ES 2126057T3
Authority
ES
Spain
Prior art keywords
hexahidronaftaleno
derivatives
ester
preparation
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94300557T
Other languages
English (en)
Inventor
Sadao Ishihara
Hiroshi Kogen
Teiichiro Koga
Eiichi Kitazawa
Nobufusa Serizawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2126057T3 publication Critical patent/ES2126057T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C07C69/736—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

COMPUESTOS DE LA FORMULA (I): [DONDE R1 REPRESENTA UN GRUPO DE FORMULA (II) O (III), R2 ES HIDROGENO O UN GRUPO DE FORMULA -OR3; R3, R3A Y R3B SON CADA HIDROGENO, UN GRUPO DE PROTECCION DE HIDROXI, ALQUILO, ALCANESULFONILO, ALCANELSULFONILO HALOGENADO O ARILSULFONILO; R4 ES HIDROGENO O UN GRUPO DE PROTECCION DE CARBOXI; R5 ES ALQUILO, ALQUENILO, ALQUINILO, ARILO, ARALQUILO O UN POLICICLO CONDENSADO; Y W ES ALQUILENO] Y SUS SALES Y ESTERES TIENEN LA PROPIEDAD DE INHIBIR LA SINTESIS DEL COLESTEROL, Y PUEDEN ASI USARSE PARA EL TRATAMIENTO Y PROFILAXIS DE HIPERCOLESTEROLEMIA Y DE VARIOS TRASTORNOS CARDIACOS.
ES94300557T 1993-01-29 1994-01-26 Derivados de ester hexahidronaftaleno, su preparacion y sus aplicaciones terapeuticas. Expired - Lifetime ES2126057T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1306393 1993-01-29

Publications (1)

Publication Number Publication Date
ES2126057T3 true ES2126057T3 (es) 1999-03-16

Family

ID=11822687

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94300557T Expired - Lifetime ES2126057T3 (es) 1993-01-29 1994-01-26 Derivados de ester hexahidronaftaleno, su preparacion y sus aplicaciones terapeuticas.

Country Status (21)

Country Link
US (1) US5491167A (es)
EP (1) EP0609058B1 (es)
JP (1) JPH06279280A (es)
KR (1) KR100293335B1 (es)
CN (1) CN1070487C (es)
AT (1) ATE174324T1 (es)
AU (1) AU664323B2 (es)
CA (1) CA2114450A1 (es)
CZ (1) CZ285658B6 (es)
DE (1) DE69415050T2 (es)
DK (1) DK0609058T3 (es)
ES (1) ES2126057T3 (es)
FI (1) FI940424A7 (es)
HU (1) HU221852B1 (es)
IL (1) IL108432A (es)
NO (1) NO300769B1 (es)
NZ (1) NZ250771A (es)
PH (1) PH31662A (es)
RU (1) RU2114101C1 (es)
TW (1) TW411337B (es)
ZA (1) ZA94548B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
US6043064A (en) * 1993-10-22 2000-03-28 Bristol-Myers Squibb Company Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof
US5942423A (en) * 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
HUP9902352A1 (hu) * 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
TWI251591B (en) * 2000-08-07 2006-03-21 Novartis Ag Process for preparing discodermolide and analogues thereof
BR0114799A (pt) * 2000-09-06 2003-12-30 Emisphere Tech Inc Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
JP3236282B1 (ja) * 2000-10-16 2001-12-10 三共株式会社 プラバスタチンを精製する方法
RU2217141C1 (ru) * 2002-11-20 2003-11-27 Балавадзе Михаил Элизбарович Состав "витализин-1" для профилактики атеросклероза, сердечно-сосудистых заболеваний и поддерживающей терапии вирусных заболеваний
SI2152670T1 (sl) 2007-04-27 2014-04-30 Actelion Pharmaceuticals Ltd. Premoščene šestčlenske obročne spojine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS57185275A (en) * 1981-05-07 1982-11-15 Sankyo Co Ltd Tetrahydro-dum-4 and tetrahydro-isodum-4 and their derivatives
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd ３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4937264A (en) * 1986-05-05 1990-06-26 Merck & Co., Inc. Antihypercholesterolemic compounds
US4937263A (en) * 1986-05-05 1990-06-26 Merck & Co., Inc. Antihypercholesterolemic compounds
US4876279A (en) * 1986-05-05 1989-10-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4902709A (en) * 1987-03-17 1990-02-20 Merck & Co., Inc. Novel antihypercholesterolemic compounds
US4885314A (en) * 1987-06-29 1989-12-05 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
US4946864A (en) * 1988-02-01 1990-08-07 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US5021453A (en) * 1988-03-02 1991-06-04 Merck & Co., Inc. 3-keto HMG-CoA reductase inhibitors
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US4963538A (en) * 1988-06-29 1990-10-16 Merck & Co., Inc. 5-oxygenated HMG-CoA reductase inhibitors
US5130306A (en) * 1989-03-13 1992-07-14 Merck & Co., Inc. 5-Oxygenated HMG-COA reductase inhibitors
US5102911A (en) * 1989-06-09 1992-04-07 Merck & Co, Inc. 4-Substituted HMG-CoA reductase inhibitors
US5010105A (en) * 1989-06-09 1991-04-23 Merck & Co., Inc. Antihypercholesterolemic compounds
EP0415488B1 (en) * 1989-08-31 1994-04-20 Merck & Co. Inc. 7-Substituted HMG-COA reductase inhibitors

Also Published As

Publication number Publication date
RU2114101C1 (ru) 1998-06-27
AU5472894A (en) 1994-08-04
DE69415050T2 (de) 1999-08-12
US5491167A (en) 1996-02-13
HU221852B1 (hu) 2003-02-28
CN1098099A (zh) 1995-02-01
CN1070487C (zh) 2001-09-05
AU664323B2 (en) 1995-11-09
DE69415050D1 (de) 1999-01-21
IL108432A0 (en) 1994-04-12
EP0609058B1 (en) 1998-12-09
CA2114450A1 (en) 1994-07-30
TW411337B (en) 2000-11-11
HU9400242D0 (en) 1994-05-30
KR100293335B1 (ko) 2001-09-17
JPH06279280A (ja) 1994-10-04
PH31662A (en) 1999-01-12
NO300769B1 (no) 1997-07-21
ATE174324T1 (de) 1998-12-15
CZ285658B6 (cs) 1999-10-13
NO940309D0 (no) 1994-01-28
EP0609058A3 (en) 1995-04-19
FI940424A0 (fi) 1994-01-28
HUT67740A (en) 1995-04-28
FI940424A7 (fi) 1994-11-07
NO940309L (no) 1994-08-01
EP0609058A2 (en) 1994-08-03
DK0609058T3 (da) 1999-08-16
KR940018352A (ko) 1994-08-16
IL108432A (en) 1997-09-30
NZ250771A (en) 1995-07-26
ZA94548B (en) 1994-08-29
HK1011678A1 (en) 1999-07-16
CZ18694A3 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
ES8308310A1 (es) Procedimiento para la preparacion de derivados de benzazepina.
ES2108238T3 (es) Derivados de esteres de hexahidronaftaleno, su preparacion y sus utilizaciones terapeuticas.
DK0527687T3 (da) Hidtil ukendte arylethylaminderivater, fremgansmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
NO882608D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyrideirer.
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
RU93056837A (ru) Гексагидронафталиновые сложноэфирные производные, способы их получения и фармацевтическая композиция
ES2143526T3 (es) Derivados de amida que tienen actividad antihipercolesterolemica, su preparacion y sus usos terapeuticos.
BG60249B2 (en) Thiazole compound for treatment of ulcers
ES2124214T3 (es) Gangliosidos modificados y sus derivados funcionales.
ES2123652T3 (es) 7-(2-aminoetil)-benzotiazolonas.
AR006360A1 (es) Derivados de 1,2,3,4-tetrahidronaftaleno substituidos, uso de los mismos para la preparacion de medicamentos y procedimiento para su preparacion.
DE69406323D1 (de) Substituierte Aminsäure Derivate verwendbar für die Behandlung von Arteriosclerosis
DE69715891D1 (de) Pyrazolopyridinverbindung und seine pharmazeutische verwendung
ATE46501T1 (de) Abkoemmlinge der guanidinomethylbenzoesaeure.
BR9506552A (pt) Método de inibição de integrase retroviral
ES2011427T3 (es) Derivados de la oxima de octahidronaftaleno para la inhibicion de la sintesis del colesterol, procedimientos para su preparacion y composiciones que los contienen.
ATE153666T1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
ES2001094A6 (es) Un procedimiento para la preparacion de un derivado de guanina
ES2051986T3 (es) Compuestos con actividad broncodilatadora.
ES2183492T3 (es) Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE116650T1 (de) Sulfonylamin substituierte bizyklische hydroxansäurederivate.
ES455741A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol.
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
DE69206607D1 (de) Behandlung von kognitiven störungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 609058

Country of ref document: ES